NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -20.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -20.71% | |||
| Cost of Revenue | 0.00% | 16.12% | |||
| Gross Profit | 0.00% | -70.90% | |||
| SG&A Expenses | 0.00% | 9.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 11.31% | |||
| Operating Income | 0.00% | -48.77% | |||
| Income Before Tax | 0.00% | 164.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 723.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 125.81% | |||
| Net Income | 0.00% | 435.03% | |||
| EBIT | 0.00% | -48.77% | |||
| EBITDA | 0.00% | -48.34% | |||
| EPS Basic | 0.00% | 135.22% | |||
| Normalized Basic EPS | 0.00% | 106.22% | |||
| EPS Diluted | 0.00% | 109.75% | |||
| Normalized Diluted EPS | 0.00% | 101.72% | |||
| Average Basic Shares Outstanding | 0.00% | 851.38% | |||
| Average Diluted Shares Outstanding | 0.00% | 3,336.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||